Form 4 for GH Guardant Health, Inc.
Accepted 2021-11-23 00:00:00 ET · period of report 2021-11-19 · accession 0001576280-21-000108 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-23 | 2021-11-19+ | GH | Talasaz AmirAli | Co-CEO, Dir | P - Purchase | $96.12 | +104.5K | 1.81M | +6% | +$10.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-11-23 | P | A | 100 | $98.00 | 1,853,845 | D | — | — | |
| 2 | Common | COMMON STOCK | 2021-11-19 | P | A | 37,721 | $97.82 | 1,787,066 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $97.64 to $98.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 3 | Common | COMMON STOCK | 2021-11-19 | P | A | 12,279 | $98.78 | 1,799,345 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $98.75 to $99.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 4 | Common | COMMON STOCK | 2021-11-23 | P | A | 14,900 | $96.83 | 1,853,745 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $96.50 to $97.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 5 | Common | COMMON STOCK | 2021-11-23 | P | A | 23,467 | $93.05 | 1,828,845 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $92.915 to $93.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 6 | Common | COMMON STOCK | 2021-11-23 | P | A | 5,000 | $94.00 | 1,833,845 | D | — | — | |
| 7 | Common | COMMON STOCK | 2021-11-23 | P | A | 5,000 | $95.50 | 1,838,845 | D | — | — | |
| 8 | Common | COMMON STOCK | 2021-11-23 | P | A | 6,033 | $92.42 | 1,805,378 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $91.885 to $92.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |